COO FINANCIAL STATEMENTS

The Cooper Companies, Inc — balance sheet, income statement and cash flow trends

COOThe Cooper Companies, Inc

🇺🇸 USA · US · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q2 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue4.2 B $+6.1%

Gross Profit2.7 B $+1.6%

Operating Income497.9 M $-34.3%

EBITDA865.9 M $-21.2%

Net Income235.8 M $-43.1%

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
COO	6.1%	64.4%	20.5%	5.6%
FPH	4.8%	64.2%	34.9%	20.0%
RMD	10.5%	61.2%	39.1%	27.4%
ANN	11.4%	41.9%	15.2%	6.7%
EL	7.5%	60.6%	23.0%	8.1%
Industry median	6.4%	53.7%	13.8%	3.9%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
COO	6.1%	64.4%	20.5%	5.6%
SOLV	-0.6%	53.7%	33.3%	17.3%
ALGN	2.9%	67.7%	22.2%	10.5%
BAX	5.1%	30.1%	6.5%	-9.7%
ATR	8.9%	29.0%	21.6%	10.0%
RGEN	18.2%	50.3%	22.6%	6.7%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q2 2026

Equity8.2 B $66%
Current Liabilities1.8 B $14%
Long-term Liabilities2.4 B $20%

Key Figures

YoY change

Total Assets12.5 B $+0.6%

Total Liabilities4.2 B $+2.9%

Total Equity8.2 B $-0.6%

Cash & ST Investments138.8 M $+19.4%

Total Debt2.5 B $-4.8%

Net Debt2.3 B $-6.0%

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
COO	1.27	29.9%	2.68	66.0%
FPH	2.31	6.9%	-0.39	74.1%
RMD	3.01	13.0%	-0.38	73.9%
ANN	2.36	46.2%	2.10	59.3%
EL	0.99	37.0%	1.66	60.9%
Industry median	2.40	34.8%	1.44	62.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
COO	1.27	29.9%	2.68	66.0%
SOLV	1.07	102.2%	1.64	35.2%
ALGN	1.39	2.8%	-1.04	65.7%
BAX	1.85	160.3%	10.39	30.4%
ATR	1.66	53.6%	1.41	51.6%
RGEN	9.20	32.7%	-0.56	71.8%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q2 2026 · TTM

Key Figures

YoY change

Operating Cash Flow953 M $+25.0%

Capital Expenditures383.5 M $-3.3%

Free Cash Flow569.5 M $+55.6%

Dividends Paid——

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
COO	22.5%	13.5%	9.1%	404.2%
FPH	28.4%	21.0%	7.4%	141.7%
RMD	34.2%	31.7%	2.5%	124.8%
ANN	11.7%	8.3%	3.4%	173.5%
EL	18.6%	13.2%	5.4%	228.6%
Industry median	13.8%	8.6%	3.8%	128.3%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
COO	22.5%	13.5%	9.1%	404.2%
SOLV	1.8%	-2.5%	4.3%	10.5%
ALGN	16.9%	16.8%	4.6%	160.9%
BAX	11.1%	6.3%	4.7%	-113.9%
ATR	15.6%	8.4%	7.2%	156.7%
RGEN	17.1%	13.6%	3.5%	254.3%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on COO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.